CDKN2B and idiopathic pulmonary fibrosis: Recently, lncRNA cyclin‐dependent kinase inhibitor‐2B‐antisense RNA 1 (CDKN2B‐AS1) in IPF patients was reported to predict lung cancer by regulating the p53‐signaling pathway.